论文信息 - Pertuzumab plus trastuzumab for HER2-positive metastatic urothelial cancer (mUC): Preliminary data from MyPathway. - 字舞流文

Pertuzumab plus trastuzumab for HER2-positive metastatic urothelial cancer (mUC): Preliminary data from MyPathway.

J. Hainsworth | R. Bose | C. Swanton | F. Meric-Bernstam | A. Bryce | R. Kurzrock | H. Hurwitz | H. Burris | M. Beattie | C. Sweeney | D. Spigel | D. Tayama | B. Yoo | Shuangli Guo